MichaelFDoubekMDEmerg Med, Inter Med
Internal Medicine • Great Falls, MTCritical Care Medicine
Sr. Clinician Emergency Medicine, and Internal Medicine, Board Certified
Dr. Doubek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1114 3rd ave north
Great Falls, MT 59401- Is this information wrong?
Education & Training
Providence Health & ServicesResidency, Internal Medicine, 1984 - 1987
St Louis University School of MedicineResidency, Internal Medicine, 1984 - 1984- Saint Louis University School of MedicineClass of 1983
Certifications & Licensure
OR State Medical License 1985 - Present
MT State Medical License 1990 - 2026- American Board of Internal Medicine Internal Medicine
- AHAATLS, ACLS, NALS and PALS
Clinical Trials
- Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia Start of enrollment: 2011 Apr 01
- Real-World Data Study Focused on Chronic Lymphocytic Leukemia (CLL) Patient Treatment Options and Their Effectiveness Start of enrollment: 2018 Nov 01
Publications & Presentations
PubMed
- 76 citationsIbrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis.Gabriela Pavlasova, Marek Borsky, Václav Šeda, Katerina Cerna, Jitka Osičková, Michael Doubek, Jiri Mayer, Raffaele A. Calogero, Martin Trbušek, Šárka Pospíšilová, Mat...> ;Blood. 2016 Sep 22
- 16 citationsA phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL.Ian W. Flinn, Panayiotis Panayiotidis, Boris V. Afanasyev, Ann Janssens, Sebastian Grosicki, Wojciech Homenda, Lukas Smolej, Kazimierz Kuliczkowski, Michael Doubek, Na...> ;American Journal of Hematology. 2016 Jul 3
- 160 citationsA complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an Europea...Andy C. Rawstron, Claudia Fazi, A. Agathangelidis, N. Villamor, Rémi Letestu, Josep F. Nomdedeu, Carles Palacio, Olga Stehlíková, Karl-Anton Kreuzer, S. Liptrot, David...> ;Leukemia. 2016 Apr 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
